These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 8862394)
1. Long-term maintenance of B cell immunity to influenza virus hemagglutinin in mice following DNA-based immunization. Justewicz DM; Webster RG Virology; 1996 Oct; 224(1):10-7. PubMed ID: 8862394 [TBL] [Abstract][Full Text] [Related]
2. Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus. Ivanovska N; Tchorbanov A; Prechl J; Maximova V; Voynova E; Vassilev TL Vaccine; 2006 Mar; 24(11):1830-7. PubMed ID: 16289708 [TBL] [Abstract][Full Text] [Related]
3. Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein. Pertmer TM; Robinson HL Virology; 1999 May; 257(2):406-14. PubMed ID: 10329551 [TBL] [Abstract][Full Text] [Related]
4. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice. Qiu M; Fang F; Chen Y; Wang H; Chen Q; Chang H; Wang F; Wang H; Zhang R; Chen Z Biochem Biophys Res Commun; 2006 May; 343(4):1124-31. PubMed ID: 16580631 [TBL] [Abstract][Full Text] [Related]
5. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge. Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942 [TBL] [Abstract][Full Text] [Related]
6. Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation. Chen J; Fang F; Li X; Chang H; Chen Z Vaccine; 2005 Jul; 23(34):4322-8. PubMed ID: 15925433 [TBL] [Abstract][Full Text] [Related]
7. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice. Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the vaccine potential of an influenza A viral hemagglutinin and matrix double insertion DNA plasmid. Xie H; Liu T; Chen H; Huang X; Ye Z Vaccine; 2007 Nov; 25(44):7649-55. PubMed ID: 17913307 [TBL] [Abstract][Full Text] [Related]
9. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729 [TBL] [Abstract][Full Text] [Related]
10. Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge. Vecino WH; Quanquin NM; Martinez-Sobrido L; Fernandez-Sesma A; GarcĂa-Sastre A; Jacobs WR; Fennelly GJ Virology; 2004 Aug; 325(2):192-9. PubMed ID: 15246259 [TBL] [Abstract][Full Text] [Related]
11. Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein. James CM; Abdad MY; Mansfield JP; Jacobsen HK; Vind AR; Stumbles PA; Bartlett EJ Vaccine; 2007 Feb; 25(10):1856-67. PubMed ID: 17240000 [TBL] [Abstract][Full Text] [Related]
12. Protection abilities of influenza B virus DNA vaccines expressing hemagglutinin, neuraminidase, or both in mice. Fang F; Cai XQ; Chang HY; Wang HD; Yang ZD; Chen Z Acta Virol; 2008; 52(2):107-12. PubMed ID: 18564897 [TBL] [Abstract][Full Text] [Related]
13. Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine. Asanuma H; Fujihashi K; Miyakoshi T; Yoshikawa T; Fujita-Yamaguchi Y; Kojima N; Nakata M; Suzuki Y; Tamura S; Kurata T; Sata T Vaccine; 2007 Sep; 25(39-40):6975-80. PubMed ID: 17716790 [TBL] [Abstract][Full Text] [Related]
14. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102 [TBL] [Abstract][Full Text] [Related]
15. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses. Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101 [TBL] [Abstract][Full Text] [Related]
16. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses. Johnson PA; Conway MA; Daly J; Nicolson C; Robertson J; Mills KH J Gen Virol; 2000 Jul; 81(Pt 7):1737-45. PubMed ID: 10859379 [TBL] [Abstract][Full Text] [Related]
17. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model. Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783 [TBL] [Abstract][Full Text] [Related]
18. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice. Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483 [TBL] [Abstract][Full Text] [Related]
19. DNA fusion vaccines incorporating IL-23 or RANTES for use in immunization against influenza. Williman J; Young S; Buchan G; Slobbe L; Wilson M; Pang P; Austyn J; Preston S; Baird M Vaccine; 2008 Sep; 26(40):5153-8. PubMed ID: 18456374 [TBL] [Abstract][Full Text] [Related]
20. Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice. Okamoto S; Matsuura M; Akagi T; Akashi M; Tanimoto T; Ishikawa T; Takahashi M; Yamanishi K; Mori Y Vaccine; 2009 Sep; 27(42):5896-905. PubMed ID: 19647814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]